HX3-14088-76788
3 vaccinations
12 coded responses
30 check-ins
12 free-text entries
4 call cases
- Sex
- Female
- Age at first dose
- 41-45
- ZIP prefix
- 062 / CT
- Registered
- 2021-01-11
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2020-12-21
Dose 1 — Pfizer-BioNTech
-
2021-01-11
Registered in v-safe
-
2021-01-11
Dose 2 — Pfizer-BioNTech
- 2021-01-11
- 2021-01-12
-
2021-01-13
Survey response — days 1–6 daily, dose 2MedDRA: Dysphonia, Respiratory tract congestion, Rhinorrhoea — Feeling: Poor · Site: Pain, Itching · Headache, Muscle or body aches, Fatigue or tiredness, NauseaFree text: runny nose congestion scratchy voiceMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-14
Survey response — days 1–6 daily, dose 2MedDRA: Respiratory tract congestion — Feeling: Good · Site: Pain, Redness · Headache, Muscle or body achesFree text: congestionMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-15
Survey response — days 1–6 daily, dose 2MedDRA: Injection site mass — Feeling: Good · Site: Pain, Redness, Itching · HeadacheFree text: mild lump at shot siteMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-16
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Redness, Itching · NoneAdult check-in
-
2021-01-17
Survey response — days 1–6 daily, dose 2MedDRA: Injection site swelling — Feeling: Good · Site: ItchingFree text: lump under skin at injection siteMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-01-18
- 2021-01-25
- 2021-02-01
- 2021-02-08
- 2021-02-15
- 2021-02-22
-
2021-04-12
Survey response — 3 months, dose 2MedDRA: Arthralgia, Unevaluable event — Feeling: Fair · Be unable to work, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Symptoms: horrible joint pain in all fingers. · Healthcare visit (other): x-rayMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-12
Report sent to call center — 3 months, dose 2Be unable to work · Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional1 call case(s)
- 2021-07-13
-
2021-10-03
Dose 3 — Pfizer-BioNTech
- 2021-10-03
-
2021-10-04
Survey response — days 1–6 daily, dose 3MedDRA: Chest discomfort, Dizziness — Feeling: Poor · Site: Pain, Swelling · Headache, Joint pains, Muscle or body aches, Fatigue or tirednessFree text: dizzy. tight breathing.MedDRA releases: 2024-11 · check-in free text available
-
2021-10-05
Health check-in — days 1–6 daily, dose 3Feeling: Good · Site: Pain, Redness, Swelling · HeadacheAdult check-in
-
2021-10-06
Survey response — days 1–6 daily, dose 3MedDRA: Decreased appetite — Feeling: Fair · Site: Pain, Swelling · Muscle or body aches, Nausea, Abdominal painFree text: loss appetiteMedDRA releases: 2024-11 · check-in free text available
-
2021-10-07
Survey response — days 1–6 daily, dose 3MedDRA: Ageusia, Decreased appetite — Feeling: Fair · Site: Pain, Swelling, Itching · Headache, Muscle or body aches, Fatigue or tiredness, NauseaFree text: loss of taste, loss of appetiteMedDRA releases: 2024-11 · check-in free text available
-
2021-10-08
Survey response — days 1–6 daily, dose 3MedDRA: Ageusia — Feeling: Good · Site: Pain, Swelling, Itching · HeadacheFree text: loss of tasteMedDRA releases: 2024-11 · check-in free text available
- 2021-10-10
- 2021-10-17
- 2021-10-24
- 2021-10-31
- 2021-11-07
-
2021-11-14
Survey response — day 42, dose 3MedDRA: Heart rate increased, Unevaluable event — Feeling: Fair · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Symptoms: increased pulse · Healthcare visit (other): holter monitorMedDRA releases: 2024-11 · check-in free text available
-
2021-11-14
Report sent to call center — day 42, dose 3Get care from a doctor or other healthcare professionalTelehealth, virtual health, or email health consultation · 1 call case(s)
- 2021-11-15
- 2021-11-15
- 2022-01-02
-
2022-04-03
Survey response — 6 months, dose 3MedDRA: Arrhythmia, Supraventricular tachycardia — Feeling: Good · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: heart rythm/ SVT.MedDRA releases: 2024-11 · check-in free text available
-
2022-04-03
Report sent to call center — 6 months, dose 3Get care from a doctor or other healthcare professionalOutpatient clinic or urgent care clinic visit · 1 call case(s)
- 2022-04-05
-
2022-10-03
Survey response — 12 months, dose 3MedDRA: Arthralgia, Blood cholesterol increased, Fatigue, Hepatic enzyme increased, Pain in extremity — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visitFree text: Elevated Liver enzymes, high cholesterol, severe arthritis like pain in hands, fatigue.MedDRA releases: 2024-11 · check-in free text available
-
2022-10-03
Report sent to call center — 12 months, dose 3Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prTelehealth, virtual health, or email health consultation · Outpatient clinic or urgent care clinic visit · 1 call case(s)
- 2022-10-05
- 2022-10-05
- 2022-10-05
- 2022-10-05
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-21 | Pfizer-BioNTech | |
| 2 | 2021-01-11 | Pfizer-BioNTech | |
| 3 | 2021-10-03 | Pfizer-BioNTech | No |
Call center
4 call center cases
4 unsuccessful
1 wait over 3 months for a first call
Free text
Release 1 — days 1–6 daily, dose 2
Systemic reaction (other): runny nose congestion scratchy voice
Systemic reaction (other): congestion
Release 2 — days 1–6 daily, dose 2
Systemic reaction (other): mild lump at shot site
Systemic reaction (other): lump under skin at injection site
Release 7 — 3 months, dose 2
Release 10 — days 1–6 daily, dose 3
Systemic reaction (other): dizzy. tight breathing.
Systemic reaction (other): loss appetite
Systemic reaction (other): loss of taste, loss of appetite
Systemic reaction (other): loss of taste
Release 10 — day 42, dose 3
Release 11 — 6 months, dose 3
Symptoms: heart rythm/ SVT.
Release 12 — 12 months, dose 3
Symptoms: Elevated Liver enzymes, high cholesterol, severe arthritis like pain in hands, fatigue.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Unevaluable event | ✓ | ✓ | ✓ |
| SD | Arrhythmia | · | · | ✓ |
| SD | Arthralgia | ✓ | ✓ | ✓ |
| SD | Blood cholesterol increased | · | · | ✓ |
| SD | Fatigue | · | · | ✓ |
| SD | Heart rate increased | · | · | ✓ |
| SD | Hepatic enzyme increased | · | · | ✓ |
| SD | Pain in extremity | · | · | ✓ |
| SD | Supraventricular tachycardia | · | · | ✓ |
| SRO | Ageusia | · | · | ✓ |
| SRO | Chest discomfort | · | · | ✓ |
| SRO | Decreased appetite | · | · | ✓ |
| SRO | Dizziness | · | · | ✓ |
| SRO | Dysphonia | ✓ | ✓ | ✓ |
| SRO | Injection site mass | ✓ | ✓ | ✓ |
| SRO | Injection site swelling | ✓ | ✓ | ✓ |
| SRO | Respiratory tract congestion | ✓ | ✓ | ✓ |
| SRO | Rhinorrhoea | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release